50 Gastrointestinal Motility Disorders: Gastric and Intestinal Manifestations GLP-1 RAs reduce GI motility and prolong intestinal transit time, effects that have raised concerns regarding an increased risk of gastroparesis, intestinal obstruction, or ileus
PubMed Gwyer, D., Wragg, N.M., Wilson, S.L
By initiating the breakdown of L-tyrosine in the proximal region of the small intestine with consequent reduction of the quantity reaching the colon and by competing with the native gut microbiota in the colon implicated in p-cresol generation from L-tyrosine, the therapeutic strain exerts its activity in CKD patients
The Evidence-Based Truth About Stacking CJC-1295 and MK-677 Here's the honest answer: most peptide stacks promoted online are marketing constructs, not evidence-based protocols
Its time to step into the real game-changer IV Glutathione for skin whitening
K.SinghA.de AraujoA.McDougleM.VergaraM.et al (2021)